FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048349423> ?p ?o ?g. }

• W3048349423 endingPage "784" @default.
• W3048349423 startingPage "780" @default.
• W3048349423 abstract "Abstract Alfuzosin is a medication approved by the US Food and Drug Administration to treat benign prostatic hyperplasia symptoms. Bioequivalence studies are demanded by regulatory authorities to evaluate the expected in vivo biological similarity of 2 formulations of a medication. The aim of this study is to assess the bioavailability of the generic (test) and branded (reference) formulations of 10‐mg alfuzosin extended‐release tablets after oral administration to healthy adults under fed conditions. The study used a comparative randomized, single‐dose, 2‐way crossover open‐label study design. Thirty‐three participants were recruited and completed the clinical assessment. The pharmacokinetic parameters maximum plasma concentration (C max ), area under the plasma concentration–time curve (AUC 0‐t ), AUC extrapolated to infinity (AUC 0‐∞ ), time to maximum concentration, and elimination half‐life were estimated to prove bioequivalence. The confidence intervals for the log‐transformed test/reference ratios for alfuzosin 110.7% (98.0–124.9) and 112.0% (101.9–123.1) for C max and AUC 0‐t respectively, which are within the allowed limits specified by the regulatory authorities (80–125% for C max and AUC 0‐t ). The test formulation can therefore be prescribed as an alternative to the reference for symptomatic treatment of benign prostatic hyperplasia." @default.
• W3048349423 created "2020-08-13" @default.
• W3048349423 creator A5010647908 @default.
• W3048349423 creator A5020322156 @default.
• W3048349423 creator A5036189356 @default.
• W3048349423 creator A5046360427 @default.
• W3048349423 creator A5053095507 @default.
• W3048349423 creator A5056983071 @default.
• W3048349423 creator A5058078198 @default.
• W3048349423 creator A5083331003 @default.
• W3048349423 date "2020-08-07" @default.
• W3048349423 modified "2023-10-09" @default.
• W3048349423 title "Pharmacokinetics and Bioequivalence Estimation of Two Formulations of Alfuzosin Extended‐Release Tablets" @default.
• W3048349423 cites W1964199329 @default.
• W3048349423 cites W1966152347 @default.
• W3048349423 cites W1974313800 @default.
• W3048349423 cites W1983874969 @default.
• W3048349423 cites W1988484382 @default.
• W3048349423 cites W1989193832 @default.
• W3048349423 cites W2000632953 @default.
• W3048349423 cites W2008736119 @default.
• W3048349423 cites W2009773951 @default.
• W3048349423 cites W2033123580 @default.
• W3048349423 cites W2034776085 @default.
• W3048349423 cites W2068097319 @default.
• W3048349423 cites W2086157441 @default.
• W3048349423 cites W2107894298 @default.
• W3048349423 cites W2160729419 @default.
• W3048349423 cites W2475148409 @default.
• W3048349423 cites W2045031957 @default.
• W3048349423 cites W2109522985 @default.
• W3048349423 doi "https://doi.org/10.1002/cpdd.860" @default.
• W3048349423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32770667" @default.
• W3048349423 hasPublicationYear "2020" @default.
• W3048349423 type Work @default.
• W3048349423 sameAs 3048349423 @default.
• W3048349423 citedByCount "7" @default.
• W3048349423 countsByYear W30483494232022 @default.
• W3048349423 countsByYear W30483494232023 @default.
• W3048349423 crossrefType "journal-article" @default.
• W3048349423 hasAuthorship W3048349423A5010647908 @default.
• W3048349423 hasAuthorship W3048349423A5020322156 @default.
• W3048349423 hasAuthorship W3048349423A5036189356 @default.
• W3048349423 hasAuthorship W3048349423A5046360427 @default.
• W3048349423 hasAuthorship W3048349423A5053095507 @default.
• W3048349423 hasAuthorship W3048349423A5056983071 @default.
• W3048349423 hasAuthorship W3048349423A5058078198 @default.
• W3048349423 hasAuthorship W3048349423A5083331003 @default.
• W3048349423 hasBestOaLocation W30483494232 @default.
• W3048349423 hasConcept C112705442 @default.
• W3048349423 hasConcept C121608353 @default.
• W3048349423 hasConcept C126322002 @default.
• W3048349423 hasConcept C126894567 @default.
• W3048349423 hasConcept C142724271 @default.
• W3048349423 hasConcept C181389837 @default.
• W3048349423 hasConcept C204787440 @default.
• W3048349423 hasConcept C27081682 @default.
• W3048349423 hasConcept C2776235491 @default.
• W3048349423 hasConcept C2777056448 @default.
• W3048349423 hasConcept C2779478474 @default.
• W3048349423 hasConcept C2780546585 @default.
• W3048349423 hasConcept C3018890749 @default.
• W3048349423 hasConcept C42404028 @default.
• W3048349423 hasConcept C44249647 @default.
• W3048349423 hasConcept C71924100 @default.
• W3048349423 hasConcept C76318530 @default.
• W3048349423 hasConcept C87813604 @default.
• W3048349423 hasConcept C98274493 @default.
• W3048349423 hasConceptScore W3048349423C112705442 @default.
• W3048349423 hasConceptScore W3048349423C121608353 @default.
• W3048349423 hasConceptScore W3048349423C126322002 @default.
• W3048349423 hasConceptScore W3048349423C126894567 @default.
• W3048349423 hasConceptScore W3048349423C142724271 @default.
• W3048349423 hasConceptScore W3048349423C181389837 @default.
• W3048349423 hasConceptScore W3048349423C204787440 @default.
• W3048349423 hasConceptScore W3048349423C27081682 @default.
• W3048349423 hasConceptScore W3048349423C2776235491 @default.
• W3048349423 hasConceptScore W3048349423C2777056448 @default.
• W3048349423 hasConceptScore W3048349423C2779478474 @default.
• W3048349423 hasConceptScore W3048349423C2780546585 @default.
• W3048349423 hasConceptScore W3048349423C3018890749 @default.
• W3048349423 hasConceptScore W3048349423C42404028 @default.
• W3048349423 hasConceptScore W3048349423C44249647 @default.
• W3048349423 hasConceptScore W3048349423C71924100 @default.
• W3048349423 hasConceptScore W3048349423C76318530 @default.
• W3048349423 hasConceptScore W3048349423C87813604 @default.
• W3048349423 hasConceptScore W3048349423C98274493 @default.
• W3048349423 hasIssue "7" @default.
• W3048349423 hasLocation W30483494231 @default.
• W3048349423 hasLocation W30483494232 @default.
• W3048349423 hasOpenAccess W3048349423 @default.
• W3048349423 hasPrimaryLocation W30483494231 @default.
• W3048349423 hasRelatedWork W2012695707 @default.
• W3048349423 hasRelatedWork W2018887812 @default.
• W3048349423 hasRelatedWork W2106589420 @default.
• W3048349423 hasRelatedWork W2351153160 @default.
• W3048349423 hasRelatedWork W2805587266 @default.
• W3048349423 hasRelatedWork W2995712274 @default.

• next